Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCH486757 in chronic idiopathic cough
2006-002165-39Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of SCH-486757 in chronic idiopathic cough (CIC), sponsored by Merck & Co. Primary endpoints: Change from baseline in cough reflex sensitivity and Reduction in cough severity by 24-hour cough counting. Started Oct 2006; status: completed.
02
Drugs
SCH-486757
03
Conditions
chronic idiopathic cough (CIC)
Beyond the preview
Go deeper on 2006-002165-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002165-39.